Get started

Healthcare

A Low Beta Way to Play Biopharma IndustryAttached is a piece about SWKH in which I discuss the value within the company, and I suggest it as a way of exposure to the healthcare technology sector without the risk. How is that possible? SWKH uses debt investments when making acquisitions in companies. Debt investments are usually the first investments to be paid back in full when a company undergoes liquidation / bankruptcy. Give it a read and let me know what y'all think. rockvuecapital.wordpress.com All the best, RC
SLong
by BrandonBeylo
Biotech (IBB) - trade of the yearIBB is at multi-year cross roads. Ideal for straddles / strangles. A dropping RSI points to a weekly downtrend. Both trade ideas are plotted. From a fundamental perspective, I believe @realdonaldtrump is right, biotech is getting away with murder. I get one of my meds from overseas because it's 1/182 the cost. Yes, you read it right. It costs me $1 there and $182 here for 10 pills. North America has one of the most affordable: 1. housing, 2. food, 3. cars, 4. Gas, 5. tech, 6. Financial Markets anywhere in the world. But what is charged for healthcare is OUTRAGEOUS. An open heart surgery done in India, China, Malaysia, Singapore, Russia costs $50,000 including business class airfare and 5 star accommodations ($20,000 is surgery cost) . In USA it is $250,000. This is a topic that Dems and Republicans are aligned on, it's very important for the most powerful country in the world to have affordable health care and thereby provide capability for it's citizens to live a happy meaningful life. Reducing healthcare costs should also increase profits for S&P by about 10% within the next 3 years as it's one of the major expense for any company.
NASDAQ:IBBShort
by iamajeya
Long term potential (1-3 months)Haven't posted on here in a bit but wanted to share my thoughts and most recent investment in $RNVA. I bought into RNVA on Tuesday at 0.083 per share for a little over 12k shares. I heard about the company through the penny stock subreddit and did some DD and decided to make an investment into it. My thoughts are as follows- Contrary to what Stocktwits believed yesterday, this is not a stock to get rich quick from. Many people have the pipe dream of this stock becoming the next $DRYS or $ETRM. Most likely not gonna happen but I would not complain if it did. The company is facing an impending reverse split if it cannot maintain $1+ a share by March for 10 days. The first thing I'm watching for is for us to reach $1 a share. If we can do that within the next few months and stay above it for 10 days the reverse split will be pushed back or not necessarily entirely. RNVA appears to have the motivation to see it reach $1 a share and to avoid an R/S, however at the end of the day it may not come near $1. In the event that it doesn't and a R/S occurs the stock soars to the company price target of $18.5 a share. Just some thoughts In it for the long haul
RLong
by Cryptocol
Asterias Biotherapeutics, Inc. triangle breakout Yesterday AST closed its session gapping up and breaking an upward triangle which might become a strong bullish opportunity. Although general downward motion is still intact, double bottom which was formed at the beginning of July and triangle breakout have every chance to finish with bearish mood. We would project the price to go up and reach at least $3.60 where it might stumble upon a gap resistance and trade down. For more ideas visit mercurius.wordpress.com
ALong
by AleksandrLombrozo
OvaScience Inc volatility and volume are increasingWith increased volume and bullish engulfing pattern which finished double bottom formation, OVAS is an excellent pick to buy this week. Last week global fertility company reported ($0.62) EPS for the quarter, topping analysts’ consensus estimates of ($0.78) by $0.16. The business earned $0.19 million during the quarter, compared to analysts’ expectations of $0.21 million. The business’s revenue was up 530.0% compared to the same quarter last year. For more ideas visit: mercuriusam.wordpress.com
OLong
by AleksandrLombrozo